Lexaria Bioscience Stock Forum

$Lexaria Bioscience(LEXX.US)$
Company AnnouncementsLexaria Bioscience Showcases Drug Delivery Breakthrough
Lexaria Bioscience Corp. (LEXX) has released an update.                  Lexaria Bioscience Corp., a leader in drug delivery platforms, will present its latest advancements in improving GLP-1 drugs using its DehydraTECH technology at the 14th Annual LD Micro Invitational in New York. CEO Chris Bunka is set to discuss recent discoveries and forthcoming studies that could significantly impact...

$Lexaria Bioscience(LEXX.US)$ nice slow climb!

$Lexaria Bioscience(LEXX.US)$ Lexaria To Begin Diabetes And Weight Loss Animal Study WEIGHT-A24-1
Benzinga· 4 mins ago

$Lexaria Bioscience(LEXX.US)$ glp is like AI.. everyone's chasing the problem with bioscience biotech to go from phase one phase two phase 3 human trials final most companies never make it that far it's a series of disappointments by the time it ever gets approved Lily will be a 2 trillion dollar company

$Lexaria Bioscience(LEXX.US)$ Something dont add up?

$Lexaria Bioscience(LEXX.US)$ Lexaria Announces FDA Clearance For Its Planned U.S. Phase 1b Hypertension Clinical Trial

$Lexaria Bioscience(LEXX.US)$ Lexaria's Submits Investigational New Drug Application For Planned Phase 1B Trial Of DehydraTECH-CBD

$Lexaria Bioscience(LEXX.US)$ Lexaria's Technology Lowers Blood Glucose More Effectively Than Rybelsus(R)-Branded GLP-1 Drug Semaglutide Alone in Human Pilot Study
Accesswire· 1 min ago

$Lexaria Bioscience(LEXX.US)$ Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs
GlobeNewswire· 5 mins ago